Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Browse our blog for an insight into the vital work our researchers are doing to tackle dementia. We also explain more about the different types, symptoms and risk factors of dementia, busting the jargon and offering helpful tips and advice.

Breathing the same air matters for scientists. Looking forward to Translation 2024

A short clip of Professor Simon Thompson explaining why Translation 2024 is important for dementia researchers involved with big data, delivering trials and undertaking experimental medicine.

DPUK's NTAD study finds MEG brain scanners are very sensitive to Alzheimer's disease

Juliette Lanksey at the University of Cambridge is part of the team that has recently completed the New Therapeutics in Alzheimer's Disease study (NTAD) as part of the Experimental Medicine Hub.

What are biomarkers and why are they important in dementia research?

Recent advances in blood-based biomarkers have led to headlines about potential blood tests for diseases such as Alzheimer’s. In this blog post, we explore how researchers can use biomarkers to see dementia-related changes in the brain, track disease onset and progression, and test the effectiveness of promising drugs and potential treatments.

Insights from OHBM 2023 with Gaurav Bhalerao, Our Postdoctoral Researcher

Last month, our Post doc researcher, Gaurav Vivek Bhalerao , attended the Human Brain Mapping 29th Annual Meeting, Montreal, Canada (22-26 July 2023). We sit down with Gaurav to chat about his journey and story and what insights he'd like to share with us.

New study: Estimating the association between Facebook adoption and well-being in 72 countries

A new study published in the Royal Society Open Science journal, researchers delved into the complex relationship between Facebook adoption and well-being across 72 countries.

DPUK at AAIC 2023 - A Week of Collaboration and Inspiration

In this blog post, we highlight the participation of Dementias Platform UK (DPUK) at the Alzheimer's Association International Conference (AAIC) 2023! From fostering collaboration at the Networking & Neuroscience event to sharing about our transformative projects.

Datathon 2023: A Journey Towards New Insights

This year's Datathon focused on Cognitive Assessment Tools, offering participants a unique opportunity to study diverse datasets and uncover the relationship between cognitive tests and data analysis possibilities.

Exploring Great Minds

In this enlightening blog post, we delve into the world of the Great Minds initiative, a valuable resource for dementia research. Dr. Ivan Koychev shares his insights about this project.

Art workshops find beautiful brains

How art workshops have engaged African and Caribbean communities about how awesome the brain can be - even as we age.

Translation 2023 - Watch the speakers online, on demand!

We have already announced the dates for Translation 2024, but you can still watch the key speakers from our inaugural conference featuring sessions on Data, Experimental Medicine and Trials Delivery. Read about the event and watch recordings of the speakers our YouTube channel.

Data curation in scientific research: how does data curation work at DPUK?

Discover how DPUK uses data curation to make information accessed via our Data Portal efficient for researchers studying dementia.

In conversation: Postdoctoral researcher Gaurav Bhalerao talks about the significance of neuroimaging studies

Gaurav Bhalerao is a postdoctoral researcher currently working in the Dementias Platform UK (DPUK) project. His research interests include neuroimaging in psychiatry, machine learning, and computational modelling of brain stimulation. In this one-on-one discussion, he takes time to go into greater depth on specific aspects of his research work in imaging studies.

Exercise alters brain chemistry and prevents dementia - here’s how

We’ve all heard that exercise is good for us, mainly how it strengthens our body and helps us prevent diseases. But many people don’t know about the other important benefits of exercise – that it can help in reducing ageing too.

We did it! Team DPUK hikes 26 miles for dementia research

On Saturday 24 September 2022, five members of team DPUK hiked 26 miles in the Peak District to raise money for Alzheimer's Research UK.

DPUK researcher picks ‘top 5’ highlights of AAIC dementia research conference

Last month, dementia researchers from around the world flocked to San Diego for the latest edition of the Alzheimer’s Association International Conference (AAIC) – the world’s biggest dementia research conference. Among the attendees was Dr Ludovica Griffanti, an Alzheimer’s Association Research Fellow at Oxford University who co-leads DPUK’s imaging pipelines project. On World Alzheimer’s Day 2022, Dr Griffanti picks out some of her highlights from the packed conference programme.

Early-career focus: Melek Karadag-Assem

Melek Karadag-Assem is a research assistant on the DPUK-funded New Therapeutics in Alzheimer’s Disease (NTAD) and Synaptic Health in Neurodegeneration (SHINE) studies, based at the University of Cambridge. On World Alzheimer’s Day 2022, we spoke to Melek about her background, her work on NTAD and SHINE, and her plans for the future.

A trip for brain health: can travel therapy offer an innovative treatment for dementia?

We’ve all heard of music and art therapies as an effective treatment method for mental health disorders. But what about travel therapy? A study suggests that this new remedy could have a positive impact on mental wellbeing – particularly for people with dementia.

Load More